Cabaletta Bio, Inc.
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor…
Biotechnology
US, Philadelphia [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Cabaletta Bio, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCabaletta Bio, Inc. can't present revenue by segment